Reinventing Radiopharma QC: Direct, Fast & Simple

What does it take to build a new lab instrument from scratch in a highly regulated market? Lyla is a spin-off from TU Delft and Erasmus MC tackling quality control challenges in emerging radiopharmaceutical cancer treatments. Starting from a clinical need, Lyla is navigating the challenge of iterating on detector technology, hardware and software all at once while building a company from the ground up.

-Bauke van Gameren –